Clinical Trials Browser

Terminated × INDUSTRY × Pluvicto × Clear all

NCT06516510 2025-09-25

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Phase EARLY_PHASE1 Terminated

Prostatic Neoplasms

NCT03042312 2021-03-24

RESIST-PC

Phase 2 Terminated

71 enrolled 15 charts

Metastatic Castration Resistant Prostate Cancer